Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
HRTS
45
HOLDINGS
29%
ALSO IN CANC
CANC
55
HOLDINGS
24%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.9% | 5.3% | 5.3% |
|
MERCK & CO. INC. | 4.5% | 5.2% | 4.5% |
|
REVOLUTION MEDICINES, INC. | 3.6% | 5.2% | 3.6% |
 |
NOVARTIS AG | 3.2% | 4.2% | 3.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 4.4% | 3.1% | 3.1% |
HRTS Overweight Relative to CANC
|
ELI LILLY & CO | 7.5% |
|
THERMO FISHER SCIENTIFIC INC | 5.3% |
|
KODIAK SCIENCES, INC. | 3.8% |
|
UNITEDHEALTH GROUP INC | 3.4% |
 |
NOVO NORDISK A/S-B | 3.3% |
|
DANAHER CORP | 3.1% |
|
CYTOKINETICS INC | 3.0% |
|
VERTEX PHARMACEUTICALS INC | 3.0% |
|
ABBOTT LABORATORIES | 2.9% |
|
GILEAD SCIENCES INC | 2.4% |
HRTS Underweight Relative to CANC
|
GENMAB A/S SPONSORED ADR | -5.3% |
|
COGENT BIOSCIENCES INC | -4.5% |
|
HALOZYME THERAPEUTICS INC | -3.8% |
|
BEIGENE LTD. SPONSORED ADR | -3.7% |
|
EXELIXIS INC | -3.6% |
|
CG ONCOLOGY, INC. | -2.4% |
|
ENLIVEN THERAPEUTICS, INC. | -2.4% |
|
IMMUNOME, INC. | -2.3% |
|
IDEAYA BIOSCIENCES, INC. | -2.2% |
|
RELAY THERAPEUTICS, INC. | -2.2% |